# Detecting an MCI and Amyloid Digital Neuro Signature(DNS) Using Altoida's Multimodal Digital Biomarkers.

> **NCT06223438** · — · COMPLETED · sponsor: **Altoida** · enrollment: 614 (actual)

## Conditions studied

- Alzheimer Disease
- MCI

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06223438
- **Lead sponsor:** Altoida
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-12
- **Primary completion:** 2024-12-15
- **Final completion:** 2025-01-10
- **Target enrollment:** 614 (ACTUAL)
- **Last updated:** 2025-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06223438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06223438, "Detecting an MCI and Amyloid Digital Neuro Signature(DNS) Using Altoida's Multimodal Digital Biomarkers.". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06223438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*